Products

Cardiomo
Cardiomo, Inc.
Cardiology AI
Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.

See all 1 product →

About Cardiomo

Cardiomo is a healthcare AI company that develops miniature wearable patches for continuous and remote health monitoring. Their platform collects vital signs such as ECG, respiration, skin temperature, and body movement via a mobile application. This data is then analyzed by an artificial intelligence engine in a HIPAA-compliant cloud, enabling medical professionals to detect cardiovascular disease symptoms and monitor patients in real-time.

The Cardiomo system aims to provide preventive care through live cardiac monitoring over extended periods and offers event prediction to detect medically actionable events before they occur. The wearable patch is waterproof, suitable for long-term wear, and has a battery life of up to 10 days. The company emphasizes its medical-grade data, which is designed to be usable by doctors, and its smart decision-making tools, including event annotations for faster diagnosis. Cardiomo’s technology is positioned to reduce the distance between patient and practitioner, ensuring a safe and equitable system with positive patient feedback.

Focus Areas

Remote Patient Monitoring Cardiovascular Disease Detection Wearable Technology Artificial Intelligence in Healthcare Preventive Care Cardiac Monitoring

Business Intelligence

TechnologyCloud-based HIPAA compliant analytic system, AI-powered software, proprietary algorithms, wearable patch with biosensors

What Physicians Need to Know

Specialization
Cardiomo specializes in real-time, continuous, and comfortable remote cardiac monitoring using a non-invasive wearable patch and AI-powered algorithms. They focus on early detection of heart diseases, including arrhythmias and other cardiac events, and providing instant notifications to patients, relatives, and caregivers.
Key Differentiators
Cardiomo's key differentiators include its proprietary AI algorithms trained to detect early symptoms of heart diseases with high accuracy (99.63%), a waterproof wearable patch with a long battery life (5-10 days), and a comprehensive ecosystem that includes the patch, a mobile app, and a HIPAA-compliant cloud-based analytical system.
Technology Stack
Their technology stack comprises a wearable patch with biosensors for vital signs (ECG/Heart Rate Variability, Skin Temperature/Respiratory Rate, Body Position/Fall Detection, Activity/Sleep Quality), proprietary AI algorithms for data analysis and event detection, a mobile application for user-friendly information and alerts (Android and iOS), and a cloud-based HIPAA-compliant analytical system (CardiomoCloud). Data transmission occurs via Bluetooth from the patch to the mobile device, then to the cloud.
Physician Tip

For physicians, Cardiomo offers several advantages: real-time remote cardiac monitoring for long-term preventive care, event annotations for faster diagnosis, and event prediction to detect likely medically actionable events before they occur. The system provides actual ECG recordings trusted by clinicians and a data dashboard with an alert system for unusual behavior. This can lead to earlier interventions, reduced readmission rates, and improved patient outcomes, especially for individuals with CVDs or those at high risk.

While specific integrations with Electronic Health Record (EHR) systems are not explicitly detailed, Cardiomo's cloud-based HIPAA-compliant system and its focus on providing data for doctors online suggest potential for interoperability. The broader healthcare AI landscape emphasizes data interoperability for ambulatory monitoring of cardiovascular disease to integrate information from various sensors, devices, and software applications.

Products by Cardiomo

1 product in the directory

Cardiomo
Cardiomo, Inc.
Cardiology AI
Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.

What the Web Says

Cardiomo is a wearable health monitoring system designed for continuous, real-time cardiac monitoring, particularly for individuals aged 45 and above or those with existing heart conditions. The device uses a patch with biosensors to track vital signs like EKG/ECG, heart rate, respiratory rate, and skin temperature, and utilizes AI to analyze data and send alerts to patients, relatives, and healthcare providers in case of abnormalities or critical events. While the product aims to provide early detection of arrhythmias and other heart diseases, some user reviews express disappointment with product performance and customer support.

Overall: Mixed

Strengths

  • Continuous 24/7 heart monitoring with EKG/ECG, heart rate, respiratory rate, and skin temperature tracking.
  • AI-powered analysis and early detection of arrhythmias and other cardiac events.
  • Real-time alerts and notifications to patients, relatives, and healthcare providers.
  • Non-invasive wearable patch design.
  • Long battery life (up to 7-10 days) compared to some competitors.
  • Potential to reduce hospital admissions and re-admissions.

Limitations

  • Some users reported disappointment with product performance and support.
  • All positive reviews seemed suspicious to some users.
  • Difficulty getting responses from customer service.
  • Concerns about the accuracy of heart rate monitoring during workouts when worn on the wrist (for a similar device, CardioMood).
  • App and web portal for a similar device (CardioMood) were described as very 'medical' and not user-friendly for general fitness tracking.

Based on reviews from: Reddit, Marche Health, Cardiomo Spinoff.com, Wareable, Cardiomo (Official Website), YouTube, CardioMood Review

Last updated: 2026-09-30

Videos

News, demos, and interviews about Cardiomo.

Loading videos...

Videos load interactively. If none appear, search YouTube for Cardiomo →

View all on YouTube

Press & Coverage

Wareable
Cardiomo's AI-powered smart patch wants to keep tabs on your heart
Cardiomo developed an AI-powered smart patch designed to detect heart problems and alert users or caregivers. The device monitors heart rate, breathing rate, and skin temperature, aiming to recognize up to 40 diseases including strokes and heart attacks.
2017-03
Tracxn
Cardiomo - 2026 Company Profile, Team, Funding & Competitors
Cardiomo, founded in 2016, is a seed-stage company based in New York City that develops smart patches for monitoring cardiac diseases. The company has raised an undisclosed amount in funding from investors including Techstars and Plug and Play Tech Center, with its latest funding round being a grant in December 2019.
2026-07
Cardiomo
CARDIOMO SPINOFF.COM
Cardiomo's wearable technology offers 24/7 monitoring of heart vitals to detect potential strokes or heart attacks. The company has applied for FDA approval in the US and is seeking partners for CE Mark approval in Europe.
unknown
Cardiomo
Posts - Cardiomo
Cardiomo is ISO 13485:2016 certified, a crucial step for selling medical devices in the European Union. The company has also partnered with Cardiologie Centra Nederland for a capstone study on heart rhythm monitoring in post-COVID patients.
unknown
PitchBook
Cardiomo 2026 Company Profile: Valuation, Funding & Investors
Cardiomo is a developer of miniature wearable patches for continuous and remote health monitoring. Its platform collects vital signs and uses an AI engine to analyze data, helping medical professionals detect cardiovascular disease symptoms.
2026-11

Frequently Asked Questions

Cardiomo's AI-powered solution continuously monitors vital signs such as ECG/heart rate variability, skin temperature, respiratory rate, body position, activity, and sleep quality. Its proprietary algorithms are trained to detect arrhythmias and other cardiac events, providing early warnings for heart diseases.
Cardiomo ensures compliance with HIPAA and GDPR by implementing robust security measures. All data is encrypted at rest using AES-256 and in transit using TLS 1.3. They also utilize role-based access control, secure AWS infrastructure, regular penetration testing, and documented incident response procedures.
Cardiomo offers various pricing plans, including options for up to 25 active clients, up to 200 active users (with volume discounts on devices), and custom enterprise solutions for unlimited users. These plans can include features like AI-generated reports, an AI Health Assistant, personalized recommendations, and predictive analytics.
Cardiomo provides different levels of support depending on the plan. This can range from email support with a 48-hour response time for smaller plans to priority support with a 24-hour response for business plans, and 24/7 premium support for enterprise clients.
While general information about Cardiomo's integration capabilities is limited, their Enterprise pricing plan explicitly mentions custom EHR/EMR integrations, suggesting that such functionality is available for larger organizations.
Cardiomo has conducted pilot projects with major state healthcare institutions and private clinics in Ukraine, Austria, and Portugal. They have also partnered with a German telecommunication provider, Telefonica, for network integration, and a major Ukrainian mobile operator for distribution.
Cardiomo is positioned as an innovative medtech company focused on continuous remote cardiac monitoring with an AI engine for early disease detection. They aim to provide preventive care and believe their wearable patch technology is the future of wearable health technologies, indicating a long-term vision in the Internet of Health Things (IoHT) market.

Investors

Who's funded Cardiomo.

Related Companies

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

CureCompanion is a healthcare technology company that specializes in virtual care solutions, offering an integrated platform of hardware and software for telemedicine. Their technology goes beyond basic video conferencing, enabling healthcare providers to conduct comprehensive virtual examinations. This includes the ability to examine skin, eyes, ears, and throat using HD cameras, listen to heart and […]

Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]

Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]

Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.